Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Advagene Biopharma Co., Ltd. (6709) Financial Statements

Advagene Biopharma Co., Ltd. Financial Overview

Advagene Biopharma Co., Ltd.'s market cap is currently NT$1.43B. The company's EPS TTM is NT$-1.51; its P/E ratio is -13.71; Advagene Biopharma Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 0.00NT$ 0.00NT$ 0.00NT$ 0.00NT$ 0.00
Gross ProfitNT$ -2.19MNT$ -2.18MNT$ -12.00MNT$ -11.60MNT$ -7.72M
Operating IncomeNT$ -70.92MNT$ -70.82MNT$ -93.34MNT$ -119.81MNT$ -94.43M
EBITDANT$ -68.73MNT$ -67.09MNT$ -80.07MNT$ -106.69MNT$ -84.83M
Net IncomeNT$ -68.29MNT$ -69.42MNT$ -92.11MNT$ -118.38MNT$ -92.69M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 134.83MNT$ 202.32MNT$ 125.19MNT$ 103.01MNT$ 223.83M
Total AssetsNT$ 166.51MNT$ 232.21MNT$ 147.93MNT$ 140.84MNT$ 260.41M
Total DebtNT$ 3.97MNT$ 6.57MNT$ 870.00KNT$ 2.57MNT$ 4.40M
Net DebtNT$ -51.37MNT$ -46.25MNT$ -64.32MNT$ -15.44MNT$ -9.93M
Total LiabilitiesNT$ 14.26MNT$ 11.67MNT$ 7.97MNT$ 9.08MNT$ 10.84M
Stockholders' EquityNT$ 152.25MNT$ 220.54MNT$ 139.96MNT$ 131.76MNT$ 249.57M
Cash Flow
Free Cash FlowNT$ -66.34MNT$ -71.12MNT$ -77.70MNT$ -119.56MNT$ -67.70M
Operating Cash FlowNT$ -64.03MNT$ -70.64MNT$ -77.70MNT$ -109.35MNT$ -67.18M
Investing Cash FlowNT$ 67.69MNT$ -89.99MNT$ 26.50MNT$ 114.29MNT$ -81.52M
Financing Cash FlowNT$ -1.14MNT$ 148.26MNT$ 98.38MNT$ -1.26MNT$ 41.14M

Currency in TWD

Advagene Biopharma Co., Ltd. Earnings and Revenue History

-150M-100M-50M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Advagene Biopharma Co., Ltd. Liabilities to Assets

0150M300M450M2.5 %5 %7.5 %10 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Advagene Biopharma Co., Ltd. Cash Flow

-300M-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Advagene Biopharma Co., Ltd. Forecast EPS vs Actual EPS

Earnings >